| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |